Detalhe da pesquisa
1.
Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS).
Health Qual Life Outcomes;
17(1): 101, 2019 Jun 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31186042
2.
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial.
Lancet Microbe;
3(1): e11-e20, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34751259